The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia

ICON Clinical Research Limited, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Medical Department, Division of Psychosomatic MedicineMunich

O’Hara, Jamie

HCD Economics, University of ChesterUK

O’Mahony, Brian

Irish Haemophilia Society, Trinity CollegeDublin

Pollard, Debra

Royal Free Hospital, Trustee of Haemnet, MASAG, European Haemophilia ConsortiumLondon

Skinner, Mark

Institute for Policy Advancement Ltd, McMaster UniversityWashington

Quinn, Jennifer

BioMarin UK LtdLondon, UK

Langue:: Anglais

Périodicité:: 1 fois par an
Sujets de la revue:: Médecine, Sciences médicales de base, Sciences médicales de base, autres, Médecine clinique, Médecine clinique, autres, Pharmacie, Pharmacologie

RSS Feed de la revue

The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia

Monika Bullinger

Diandra Latibeaudiere Gardner

Hannah B Lewis

Wolfgang Miesbach

Sandra Nolte

Jamie O’Hara

Brian O’Mahony

Debra Pollard

Mark Skinner

Jennifer Quinn

Catégorie d'article: Clinical Research

Publié en ligne: 30 mai 2021

Pages: 56 - 68

DOI: https://doi.org/10.17225/jhp00176

Mots clésHaemophilia, gene therapy, patient-reported outcomes, health-related quality of life

© 2021 Monika Bullinger et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Mots clés
Haemophilia, gene therapy, patient-reported outcomes, health-related quality of life